Procter & Gamble
PG
$152.49
+1.35%
The Procter & Gamble Company is a global leader in the consumer defensive sector, manufacturing and selling a vast portfolio of household and personal care products, including iconic brands like Tide, Pampers, Charmin, and Pantene. It is a dominant market leader with over 20 brands each generating over $1 billion in annual sales, distinguished by its immense scale, global distribution, and deep brand equity. The current investor narrative centers on its resilience as a defensive staple amid economic uncertainty, with attention focused on its ability to navigate input cost pressures, sustain pricing power, and deliver consistent, profitable growth in a challenging environment for consumer goods.…
PG
Procter & Gamble
$152.49
Related headlines
Investment Opinion: Should I buy PG Today?
Rating & Thesis: Hold. PG is a high-quality defensive compounder trading at a full valuation that accurately reflects its strengths but offers limited near-term upside, requiring patience for the price to align with a more attractive entry point. Analyst sentiment is mixed but leans neutral, with recent actions including a downgrade to 'Hold' from TD Cowen alongside 'Buy' and 'Overweight' ratings from others.
Supporting Evidence: The primary valuation metric, the forward P/E of 21.11x, sits at a premium to the sector. Revenue growth is stable but anemic at 1.49% YoY. Profitability is the standout, with net margin at 18.95% and ROE at 30.71%. Free cash flow generation is exceptional at $14.85 billion TTM. The implied upside is constrained, with the stock trading closer to its 52-week high than its low, and the analyst EPS estimate range is narrow, signaling low expected volatility in fundamentals.
Risks & Conditions: The two biggest risks are 1) a de-rating of its premium P/E multiple if growth disappoints, and 2) margin compression from input cost inflation. This Hold rating would upgrade to a Buy if the forward P/E compressed meaningfully below 20x (offering a better margin of safety) or if quarterly revenue growth sustainably accelerated above 3-4%. It would downgrade to a Sell if gross margins fell persistently below 50% or if the stock broke below its 52-week low on deteriorating fundamentals. Relative to its own history and sector peers, PG is fairly valued to slightly overvalued, pricing in its quality but leaving little room for error.
Sign up to view all
PG 12-Month Price Forecast
PG is a fortress of quality trading at fortress prices. The AI assessment is neutral due to the offsetting forces of stellar fundamentals and full valuation. The stock's destiny in the next 12 months is less about company-specific execution—which is likely to remain competent—and more about the market's appetite for paying a premium for stability and low growth. The stance would upgrade to bullish on a meaningful pullback to a forward P/E near or below 20x, creating a compelling risk/reward for a long-term holding. It would turn bearish if margin trends clearly deteriorate, signaling a break in its core investment thesis of superior profitability.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $198.24 and implied upside of +30.0% versus the current price.
Average Target
$198.24
12 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
12
covering this stock
Price Range
$122 - $198
Analyst target range
Analyst coverage for Procter & Gamble is substantial, with 8 analysts providing estimates, reflecting its status as a large-cap, institutional staple. The consensus sentiment leans bullish to neutral, as evidenced by recent institutional actions including 'Buy' from UBS and 'Overweight' from Wells Fargo and JP Morgan, though there have been some cautious moves like TD Cowen shifting from 'Buy' to 'Hold'. The average target price implied by revenue and EPS estimates suggests a consensus view, though a specific average target price is not provided in the data; the estimated EPS average is $8.39 with a revenue estimate of $100.0 billion. The target range, based on EPS estimates, has a low of $8.27 and a high of $8.60, indicating a relatively tight spread of about 4.0%, which signals strong analyst conviction and agreement on the company's near-term earnings trajectory. The high target likely assumes successful execution on pricing, market share gains, and margin stability, while the low target may factor in risks like volume erosion or increased competitive pressures.
Bulls vs Bears: PG Investment Factors
The evidence is finely balanced, but the bear case currently holds a slight edge due to valuation and growth concerns. PG's fundamental strengths—superb profitability, cash flow, and defensive traits—are undeniable and provide a solid floor. However, these qualities are fully priced in at a 24.5x trailing P/E, leaving the stock vulnerable to de-rating if growth disappoints. The single most important tension in the investment debate is whether PG's premium valuation, justified by its quality and stability, can be sustained in a market environment that may increasingly penalize low-growth stocks, even defensive ones. The resolution hinges on PG's ability to demonstrate it can deliver consistent, albeit modest, earnings growth without margin erosion.
Bullish
- Exceptional Profitability & Cash Flow: PG maintains industry-leading margins with a gross margin of 51.16% and a net margin of 18.95%. This pricing power and cost discipline generate immense free cash flow of $14.85 billion TTM, funding dividends and buybacks.
- Strong Defensive Characteristics: With a beta of 0.385, PG is 61.5% less volatile than the market, a key defensive trait. Its 1.49% YoY revenue growth in a challenging quarter demonstrates the resilience of its essential product portfolio.
- High-Quality Dividend King: PG offers a stable dividend with a yield of 2.52% and a payout ratio of 61.8%, supported by robust cash generation. Its status as a Dividend King provides a reliable income stream for long-term investors.
- Superior Capital Efficiency: The company delivers an outstanding Return on Equity of 30.71%, showcasing exceptional efficiency in generating profits from shareholder capital. This metric far exceeds typical consumer staples peers.
Bearish
- Premium Valuation Demands Perfection: PG trades at a trailing P/E of 24.48x and a forward P/E of 21.11x, a significant premium to the sector. This leaves little room for multiple expansion and requires flawless execution to justify.
- Anemic Top-Line Growth: Revenue growth is stagnant, with the latest quarter showing only 1.49% YoY growth. In a market rewarding growth, PG's mature business model struggles to accelerate beyond low-single digits.
- Recent Price Weakness & Underperformance: The stock is down 8.32% over the past year and trades at 89% of its 52-week high, significantly underperforming the SPY by 31.18%. This suggests waning investor appetite for premium-priced staples.
- Vulnerability to Input Cost Pressures: While margins are currently strong, news of a second European energy crisis highlights ongoing risks to commodity and logistics costs. Sustaining a 51% gross margin could become more challenging.
PG Technical Analysis
The stock is in a corrective downtrend, having declined 8.32% over the past year and currently trading at approximately 89% of its 52-week high of $167.25, indicating it is significantly off its peak but not near its 52-week low of $137.62. This positioning suggests the stock is in a phase of consolidation and potential value discovery after a notable pullback from recent highs. Recent momentum shows a short-term rebound, with the stock up 5.18% over the past month, which contrasts sharply with its negative 1-year performance and a slight 3-month decline of 0.69%. This divergence suggests a potential near-term stabilization or relief rally within a longer-term corrective phase, though the 1-month positive momentum is notably strong against a weak broader market backdrop, as indicated by a 5.26% relative strength versus the SPY. Key technical support is anchored at the 52-week low of $137.62, while resistance looms at the 52-week high of $167.25; a sustained break above the recent high near $167 would signal a resumption of the prior uptrend, while a breakdown below $137 would confirm a deeper bearish phase. The stock's low beta of 0.385 indicates it is approximately 61.5% less volatile than the broader market, which is characteristic of a defensive staple and implies lower relative risk for position sizing during turbulent periods.
Beta
0.39
0.39x market volatility
Max Drawdown
-18.8%
Largest decline past year
52-Week Range
$138-$167
Price range past year
Annual Return
-5.2%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | +7.7% | +1.5% |
| 3m | +3.9% | +13.4% |
| 6m | +4.8% | +10.9% |
| 1y | -5.2% | +24.5% |
| ytd | +7.5% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Revenue growth is modest but stable, with the most recent quarterly revenue of $22.21 billion representing a year-over-year increase of 1.49%. The multi-quarter trend shows revenue fluctuating between approximately $19.8 billion and $22.4 billion, indicating a business in a mature, low-single-digit growth phase, which is consistent for a consumer staples giant. The Fabric Care and Home Care segment is the largest revenue driver at $7.69 billion for the latest period, underscoring the importance of its core laundry and cleaning businesses. The company is highly profitable, reporting net income of $4.33 billion and a robust gross margin of 51.16% for the latest quarter. Profitability metrics are strong and stable, with a trailing net margin of 18.95% and an operating margin of 24.26%, reflecting the company's pricing power and cost discipline. While quarterly net income has shown some variability, the underlying margin structure remains enviable for the industry. The balance sheet is solid, with a debt-to-equity ratio of 0.68, indicating a moderate and manageable level of leverage. Financial health is further supported by strong cash generation, with trailing twelve-month free cash flow of $14.85 billion and a return on equity of 30.71%, demonstrating exceptional efficiency in generating profits from shareholder capital. The current ratio of 0.70 suggests adequate, though not excessive, liquidity to meet short-term obligations.
Quarterly Revenue
$22.2B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$14.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
Given the company's substantial net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 24.48x, while the forward PE is lower at 21.11x, indicating the market expects earnings growth and a slight multiple compression. The gap between trailing and forward multiples suggests analysts anticipate modest earnings expansion in the coming year. Compared to sector averages, Procter & Gamble trades at a significant premium; its trailing PE of 24.48x is well above the typical range for stable consumer staples, and its Price-to-Sales ratio of 4.64x also reflects a premium valuation. This premium is likely justified by the company's superior brand portfolio, consistent profitability (18.95% net margin), and defensive characteristics, though it demands sustained execution. Historically, the current trailing PE of 24.48x sits above the midpoint of its own historical range observed in recent quarters, which has fluctuated between approximately 19x and 32x. Trading near the higher end of its recent historical band suggests the market is still pricing in a quality and stability premium, even after the recent price pullback, leaving limited room for multiple expansion.
PE
24.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~32x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: PG's primary financial risk is not solvency—its balance sheet is strong—but rather its dependence on maintaining premium profitability to justify its premium valuation. A compression in its gross margin from the current 51.2% due to sustained input cost inflation or intensified competition would directly pressure its 18.95% net margin and high ROE. While free cash flow is robust at $14.85 billion, a significant portion is committed to dividends (61.8% payout ratio), limiting financial flexibility for major strategic shifts. Revenue concentration is not in a single product but in a mature industry, creating an inherent growth ceiling.
Market & Competitive Risks: The paramount risk is valuation compression. Trading at a trailing P/E of 24.48x, well above typical staples multiples, PG is priced for perfection. A sector rotation away from defensive names or a rise in risk appetite could lead to multiple contraction. Its low beta of 0.385, while a defensive strength, also means it may lag significantly in strong bull markets, as evidenced by its -31.2% relative strength vs. the SPY over the past year. Competitive risks include private label incursion during economic stress and the slow but steady disruption from direct-to-consumer brands in personal care.
Worst-Case Scenario: The worst-case scenario involves a perfect storm of margin pressure from another energy/commodity shock, volume erosion as consumers trade down, and a broader market de-rating of low-growth, high-multiple stocks. This could trigger analyst downgrades and a re-pricing toward its historical valuation lows. The realistic downside is to the 52-week low of $137.62, which represents an 8.0% decline from the current price of $149.61. A more severe bear case, incorporating a deeper multiple compression, could see a drawdown approaching the stock's recent max drawdown of -18.75%, implying a potential loss of up to -19% from current levels.
FAQ
The key risks are: 1) Valuation Risk: The primary risk is multiple compression if the market re-prices its premium P/E due to low growth, posing a -8% to -19% downside to recent lows. 2) Margin Risk: Input cost inflation (e.g., energy, commodities) could pressure its industry-leading 51.2% gross margin. 3) Competitive & Demand Risk: Potential market share loss to private label or volume erosion if consumers resist price hikes. 4) Performance Risk: Its low beta (0.385) means it may significantly lag in strong bull markets, as seen in its -31.2% relative underperformance vs. the SPY over the past year.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $150 and $165, as it delivers consensus EPS of ~$8.39 and maintains its premium valuation. The Bull Case (25% probability) targets $167 to $175 on multiple expansion driven by a flight to safety and strong earnings. The Bear Case (15% probability) sees a retest of the 52-week low, with a range of $137 to $145, triggered by margin compression and a growth scare. The Base Case is most likely, assuming PG executes as expected in a mixed macro environment.
PG stock is fairly valued to slightly overvalued relative to its growth prospects. Its trailing P/E of 24.5x and forward P/E of 21.1x command a significant premium over the broader consumer staples sector, justified by its superior profitability (18.95% net margin) and defensive characteristics. However, with revenue growth of just 1.5%, the valuation implies the market is paying for stability and quality, not expansion. Compared to its own historical P/E range (approximately 19x to 32x), it sits in the upper half, suggesting limited room for multiple expansion from current levels.
PG is a good stock to buy for a specific investor profile: those seeking a low-volatility, defensive holding with a reliable dividend. However, at its current forward P/E of 21.1x, it is fairly valued to slightly overvalued, offering limited near-term capital appreciation upside. The 2.5% dividend yield and strong cash flow provide a floor. It becomes a more compelling buy on a pullback toward the $140-$145 range, which would offer a better margin of safety and a higher yield. For growth-oriented investors, it is not a good buy.
PG is unequivocally suitable for long-term investment, not short-term trading. Its low beta (0.385) and modest growth profile mean it is unlikely to generate explosive short-term gains. Its value is realized over years through dividend compounding, share buybacks, and steady earnings growth. The stock is a core holding for dividend growth and defensive allocation portfolios. A minimum holding period of 3-5 years is recommended to ride out market cycles and fully benefit from its compounding characteristics. Short-term traders would find better opportunities in more volatile, catalyst-driven names.
